Agios (AGIO) | Stock Overview & Key Data

Agios Pharmaceuticals Inc. | Healthcare

$34.33

2.23%

| Agios Stock Comparison:

Agios vs Vertex Agios vs Regeneron Agios vs Vera Therapeutics Agios vs Immunocore Holdings Agios vs Amicus Therapeutics Agios vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Agios Performance Comparison

Loading chart data...

Agios

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $33.75 High: $34.56

on June 7, 2025

52 Week Range

Low: $23.42 High: $62.58

on April 9, 2025

on November 11, 2024

All-Time High: $138.85 on January 12, 2015

Key Statistics

Market Cap i $1.9B

EPS i 11.54

P/E Ratio (TTM) i 2.89

Forward P/E i -5.49

P/B Ratio i 1.32

PEG Ratio i -5.49

Div. Yield i 0.00%

ROE i 60.26%

Beta i 0.726

Debt to Equity i 3.61

Financial Highlights

Profitability

Gross Margin i 87.57%

Operating Margin i -1,221.97%

Profit Margin i 1,798.26%

Returns and Earnings

Return on Assets (TTM) i -22.88%

Return on Equity (TTM) i 60.26%

EBITDA i $-434.7M

Net Income (TTM) i $666.0M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Agios AGIO	1.93B Small-cap	6.98%	21.22%	1.03%	-44.31%	7.82%	-27.89%	85.57%	-27.17%
Vertex VRTX	113.97B Large-cap	1.91%	0.10%	-7.25%	-2.51%	11.03%	-6.74%	76.75%	67.75%
Regeneron REGN	52.15B Large-cap	0.60%	-11.69%	-29.38%	-36.60%	-31.04%	-50.82%	-13.74%	-16.17%
Vera Therapeutics VERA	1.95B Small-cap	19.79%	3.13%	-22.53%	-53.16%	-46.21%	-41.04%	62.26%	97.39%
Immunocore Holdings IMCR	1.94B Small-cap	1.78%	32.75%	20.90%	18.18%	24.92%	-10.63%	26.61%	-13.77%
Amicus Therapeutics FOLD	1.93B Small-cap	1.48%	-0.48%	-31.71%	-36.69%	-33.83%	-38.71%	-26.23%	-43.64%

Ownership & Short Interest

Insider Ownership i 1.60%

Institutional Ownership i 107.60%

Shares Short i 4M

Short Ratio i 8.10

Short % of Shares Outstanding i 7.23%

Average 10-Day Volume i 672K

Average 90-Day Volume i 559K

Agios Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Agios would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is AGIO's 52-week high and low?

In the last 52 weeks, Agios reached a high of $62.58 (on November 11, 2024) and a low of $23.42 (on April 9, 2025).

What is the market cap and P/E ratio for AGIO?

Curious about Agios's size and valuation? Its market capitalization stands at 1.93B. When it comes to valuation, the P/E ratio (trailing twelve months) is 2.89, and the forward P/E (looking ahead) is -5.49.

Does AGIO pay dividends? If so, what's the yield?

As for dividends, Agios isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Agios's main competitors or similar companies to consider before investing?

When looking at Agios, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	113.97B	Healthcare	Biotechnology	-6.74%	76.75%
Regeneron REGN	52.15B	Healthcare	Biotechnology	-50.82%	-13.74%
Vera Therapeutics VERA	1.95B	Healthcare	Biotechnology	-41.04%	62.26%
Immunocore Holdings IMCR	1.94B	Healthcare	Biotechnology	-10.63%	26.61%
Amicus Therapeutics FOLD	1.93B	Healthcare	Biotechnology	-38.71%	-26.23%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Agios Pharmaceuticals Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Agios's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 60.26%, the Debt to Equity ratio from the most recent quarter is 3.61, and its Gross Profit Margin stands at 87.57%.

What is the recent revenue and earnings growth for AGIO?

Looking at Agios's growth, its revenue over the trailing twelve months (TTM) was $37M. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.60%, and quarterly earnings saw a YoY growth of 6.56%.

How much of AGIO stock is held by insiders and institutions?

Wondering who owns Agios stock? Company insiders (like executives and directors) hold about 1.60% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 107.60%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.